News
Article
Sponsored Content
BioPharm International Sponsored eBooks
BioPharm International Sponsored eBooks-07-15-2023Volume Issue 1
BLI Technology for Comprehensive Characterization of Biotherapeutics
Author(s):
The evolution of regulatory guidelines for biosimilars alongside improvements in knowledge and understanding provide a platform for growth in the industry. Technology to support their rapid growth must simplify and streamline processes during drug development.
Articles in this issue
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
